Vomiting after meals, persistent abdominal discomfort, or difficulty eating normal portions may appear
Sky Health Pro-Tip: Many patients find that injecting in the thigh rather than the abdomen can slightly reduce the intensity of gastrointestinal side effects while maintaining the same weight-loss efficacy
Neurological and biochemical testing Neurological and biochemical characteristics of the patients are given in Supplementary Table 2
However, its effects are milder and slower than GLP-1 drugs, so its not a direct substitute
Gather your supplies: medication vial, a new sterile syringe, alcohol pads, and a sharps container
This data is significant because it is the first robust evidence we have seen that shows what happens to GLP-1 and GIP levels in non-diabetic patients with moderate to severe kidney disease after they have a meal, explained Armin Ahmadi, postdoctoral scholar of nephrology at UC Davis Health and lead author of the study